Clinical Trial Update: A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial investigates the combination of lenalidomide with bendamustine in adults with relapsed or primary refractory Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Revlimid (lenalidomide)
• Treanda (Bendamustine)

Snippet

Sponsor: Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale | Conditions: Recurrent Adult Hodgkin Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN